1x1 image pixel for data collection
Medio de suero reducido Opti-MEM™ I
Medio de suero reducido Opti-MEM™ I
Gibco™

Medio de suero reducido Opti-MEM™ I

El medio de suero reducido Opti-MEM™ I es un medio esencial mínimo (MEM) mejorado que permite una reducción de laMás información
Promo ImagePromociones
Código de descuento:RCELL25
Save up to 29% across the cell culture workflow - research begins with cells
From now until Dec 31, get up to 29% off media, sera, buffers, reagents and other cell culture products to advance your researchConozca más
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
31985062Promo Image100 mL
31985070Promo Image500 mL
Número de catálogo 31985062
Precio (EUR)
44,40
Each
En Stock
Añadir al carro de la compra
Cantidad:
100 mL
Recurring order eligible. Learn more »
Customize this product
Precio (EUR)
44,40
Each
Añadir al carro de la compra
Ask our AI about this Product
El medio de suero reducido Opti-MEM™ I es un medio esencial mínimo (MEM) mejorado que permite una reducción de la suplementación de suero bovino fetal, por lo menos en un 50 %, sin ningún cambio en la tasa de crecimiento o la morfología. El medio Opti-MEM™ I también se recomienda cuando se van a usar reactivos de transfección de lípidos catiónicos, como el reactivo Lipofectamine™. El medio Opti-MEM™ I se puede emplear con diversas células de mamíferos adherentes y en suspensión, incluidos SP2, AE-1, CHO, BHK-21, HEK y fibroblastos primarios. Ofrecemos diversas modificaciones de Opti-MEM™ I para diferentes aplicaciones de cultivos celulares.

Esta versión de Opti-MEM™ I se ha modificado del modo siguiente:
Con
• L-glutamina
• Rojo de fenol

La formulación completa es confidencial. Si desea obtener más información, póngase en contacto con el servicio técnico.

Uso del medio Opti-MEM™ I
El medio de suero reducido Opti-MEM™ I es un medio único que contiene insulina, transferrina, hipoxantina, timidina y oligoelementos. Estos componentes adicionales permiten una reducción en la suplementación sérica de al menos un 50 %. El medio Opti-MEM™ I utiliza un sistema de tampones de bicarbonato sódico (2,4 g/l) y, por tanto, requiere un ambiente con un 5–10 % de CO2 para mantener el pH fisiológico.

Sistema cGMP de elaboración y calidad
Opti-MEM™ I se elabora en unas instalaciones que cumplen con las buenas prácticas de fabricación actuales ubicadas en Grand Island, Nueva York (EE. UU.). Las instalaciones se han registrado en la Agencia estadounidense de alimentos y medicamentos (FDA) como fabricante de dispositivos médicos y tienen la certificación según la norma ISO 13485. Para mantener la continuidad de la cadena de suministro, ofrecemos un producto Opti-MEM™ I idéntico fabricado en nuestras instalaciones de Escocia (31985-047). Estas instalaciones también se han registrado en la FDA como fabricante de dispositivos médicos y tienen la certificación según la norma ISO 13485.
Para su uso en investigación o procesos de fabricación posteriores. No apto para uso diagnóstico ni para la administración directa en seres humanos ni en animales.
Especificaciones
Línea de célulasSp2, AE-1, CHO, BHK-21 y HEK
Tipo de célulaFibroblastos primarios
Concentración1 X
Calidad de fabricacióncGMP-compliant under the ISO 13485 standard
Línea de productosGibco™, Opti-MEM™
Tipo de productoOpti-MEM I
Cantidad100 mL
Duración de almacenamiento18 meses a partir de la fecha de fabricación
Condiciones de envíoTemperatura ambiente
ClasificaciónOrigen humano
FormularioLíquido
EsterilidadEstéril con filtro
Sterilization MethodEstéril con filtro
Con aditivosGlutamina, Rojo de fenol
Unit SizeEach
Contenido y almacenamiento
Condiciones de almacenamiento: De 2 a 8 °C. Proteger de la luz
Condiciones de envío: Ambiente
Vida útil: 18 meses a partir de la fecha de fabricación
Have questions about this product? Ask our AI assisted search.
Is there any other difference between Opti-MEM I Reduced Serum Medium and Opti-MEM I Reduced Serum Medium, no phenol red besides the presence/absence of phenol red?
My cells are growing very slowly. What could be the cause of this?
Can any Gibco formulation be customized with the Gibco Media Configurator?
I noticed that Opti-MEM I Reduced Serum Medium does not contain any serum. Why do you then refer to it as "Reduced Serum Medium"?
How can I remove mycoplasma contamination from my cell culture medium?
+Show more FAQs for this product
This is an AI-powered search and may not always get things right. You can help us make it better with a thumbs up or down on individual answers or by selecting the “Give feedback" button. Your search history and customer login information may be retained by Thermo Fisher and processed in accordance with our Privacy Notice.

Customers who viewed this item also viewed



Documentos y descargas

Certificados

N.º de loteCertificate TypeDateCatalog Number(s)
3225302Certificate of Analysis27 jun 202531985047, 31985062, 31985070
3150493Certificate of Analysis22 jun 202531985047, 31985062, 31985070
3141618Certificate of Analysis06 jun 202531985047, 31985062, 31985070
3141616Certificate of Analysis06 jun 202531985047, 31985062, 31985070
3137998Certificate of Analysis04 jun 202531985047, 31985062, 31985070
Se muestran 5 resultados, busque arriba un certificado específico

Hojas de datos de seguridad

Preguntas frecuentes

We recommend using Opti-MEM I Reduced Serum Medium (Cat. No. 31985062).

Find additional tips, troubleshooting help, and resources within our Transfection Support Center.

Opti-MEM I Reduced Serum Medium, no phenol red (Cat. No. 11058021) would be the closest alternative. Both offerings contain L-glutamine. For more a stabilized L-glutamine option, Opti-MEM I Reduced Serum Medium, GlutaMAX Supplement (Cat. No. 51985034) is the recommended alternative. All Opti-MEM offerings have demonstrated performance for both reduced-serum cell culture and lipid-based transfection.

This product should be stored at 2-8 degrees C and should not be frozen. The biggest issue with accidentally freezing this product is its solubility. If this product was accidentally frozen, we recommend placing it in a 2-8 degree environment and allowing it to slowly thaw overnight. If the product is fully thawed and shows no signs of precipitation, then it should still be usable, but we cannot guarantee effectiveness.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

The formulation of Opti-MEM I Reduced Serum Medium and that of Opti-MEM I Reduced Serum Medium, no phenol red is the same except for the presence of phenol red in the former medium.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

We do provide osmolality information on the certificate of analysis. All lots of Opti-MEM I Reduced Serum Medium will meet the osmolality specification of ≥280 to ≤320 mOsm/kg.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Citations & References (23)

Citations & References
Abstract
Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth.
Authors:Mueller Cornelius; Baudler Stephanie; Welzel Hilke; Böhm Michael; Nickenig Georg;
Journal:Circulation
PubMed ID:12021231
BACKGROUND: Reactive oxygen species, such as superoxide (O(2)(-)), are involved in the abnormal growth of various cell types. Angiotensin II (Ang II) is one of the most potent inducers of oxidative stress in the vasculature. The molecular events involved in Ang II-induced proliferation of vascular smooth muscle cells (VSMCs) are ... More
Regulation of cortical dendrite development by Slit-Robo interactions.
Authors:Whitford Kristin L; Marillat Valérie; Stein Elke; Goodman Corey S; Tessier-Lavigne Marc; Chédotal Alain; Ghosh Anirvan;
Journal:Neuron
PubMed ID:11779471
Slit proteins have previously been shown to regulate axon guidance, branching, and neural migration. Here we report that, in addition to acting as a chemorepellant for cortical axons, Slit1 regulates dendritic development. Slit1 is expressed in the developing cortex, and exposure to Slit1 leads to increased dendritic growth and branching. ... More
Non-viral-mediated gene transfer of OX40 ligand for tumor immunotherapy.
Authors:Rakitina OA,Kuzmich AI,Bezborodova OA,Kondratieva SA,Pleshkan VV,Zinovyeva MV,Didych DA,Sass AV,Snezhkov EV,Kostina MB,Koksharov MO,Alekseenko IV
Journal:Frontiers in immunology
PubMed ID:39007148
BACKGROUND: Immune checkpoint blockade (ICB) is rapidly becoming a standard of care in the treatment of many cancer types. However, the subset of patients who respond to this type of therapy is limited. Another way to promote antitumoral immunity is the use of immunostimulatory molecules, such as cytokines or T ... More
Effects of an indole derivative on cell proliferation, transfection, and alternative splicing in production of lentiviral vectors by transient co-transfection.
Authors:Mier NC,Roper DK
Journal:PloS one
PubMed ID:38833479
Lentiviral vectors derived from human immunodeficiency virus type I are widely used to deliver functional gene copies to mammalian cells for research and gene therapies. Post-transcriptional splicing of lentiviral vector transgene in transduced host and transfected producer cells presents barriers to widespread application of lentiviral vector-based therapies. The present study ... More
Vinexin beta Regulates the Anchorage Dependence of ERK2 Activation Stimulated by Epidermal Growth Factor.
Authors: Suwa Akira; Mitsushima Masaru; Ito Takuya; Akamatsu Masahiko; Ueda Kazumitsu; Amachi Teruo; Kioka Noriyuki;
Journal:J Biol Chem
PubMed ID:11825889
'ERK is activated by soluble growth factors in adherent cells. However, activation of ERK is barely detectable and not sufficient for cell proliferation in non-adherent cells. Here, we show that exogenous expression of vinexin beta, a novel focal adhesion protein, allows anchorage-independent ERK2 activation stimulated by epidermal growth factor. In ... More
23 total citations

Other products to consider



Compartir número de catálogo, nombre o enlace.